Bosh sahifaGLPG • AMS
add
Galapagos NV
Yopilish kursi
26,14 €
Kunlik diapazon
26,04 € - 26,42 €
Yillik diapazon
22,00 € - 39,00 €
Bozor kapitalizatsiyasi
1,70 mlrd EUR
Oʻrtacha hajm
101,51 ming
Narx/foyda
8,36
Dividend daromadliligi
-
Asosiy maydon
AMS
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (EUR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 59,85 mln | -50,14% |
Joriy xarajat | 21,09 mln | 112,58% |
Sof foyda | -50,43 mln | -295,24% |
Sof foyda marjasi | -84,26 | -491,54% |
Har bir ulushga tushum | -0,74 | -289,74% |
EBITDA | -48,48 mln | -86,02% |
Amaldagi soliq stavkasi | 1,16% | — |
Balans
Jami aktivlari
Jami passivlari
| (EUR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 3,34 mlrd | -12,41% |
Jami aktivlari | 4,17 mlrd | -6,27% |
Jami passivlari | 1,31 mlrd | -28,43% |
Umumiy kapital | 2,86 mlrd | — |
Tarqatilgan aksiyalar | 65,94 mln | — |
Narxi/balansdagi bahosi | 0,60 | — |
Aktivlardan daromad | -3,21% | — |
Kapitaldan daromad | -4,69% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (EUR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -50,43 mln | -295,24% |
Operatsiyalardan naqd pul | -71,79 mln | 39,58% |
Sarmoyadan naqd pul | 56,56 mln | -69,02% |
Moliyadan naqd pul | -1,09 mln | 47,41% |
Naqd pulning sof oʻzgarishi | -16,80 mln | -127,39% |
Boʻsh pul | -66,59 mln | 24,78% |
Haqida
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
Tashkil etilgan
1999
Sayt
Xodimlar soni
683
